Insider Trading activities at Erasca, Inc. (ERAS)

Insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Erasca, Inc. (ERAS) since 2021 are shown in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Erasca, Inc.. Table 2 shows the detailed insider transactions. This company's CIK number is 1761918.

Total stock buying since 2021: $26,777,015.
Total stock sales since 2021: $3,753,000.
Total stock option exercises since 2021: $0.


9 insiders reported insider trading activities at Erasca, Inc. (ERAS):
Insider trading activities of Casdin Alexander W.
Insider trading activities of Hambleton Julie
Insider trading activities of Bristol James Arthur
Insider trading activities of Chen Bihua
Insider trading activities of Lim Jonathan E
Insider trading activities of Garner Ebun
Insider trading activities of Start Valerie Denise Harding
Insider trading activities of Cormorant Private Healthcare Fund Ii, Lp
Insider trading activities of Multani Pratik S

Table 1. Yearly summary of insider stock purchases, sales, and option exercises at Erasca, Inc. (ERAS).
Insider Buying Insider Sales Option Exercises
Year Shares Value Shares Value Shares Value
2024 80,000 $181,920 0 $0 0 $0
2023 2,260,000 $4,404,697 0 $0 0 $0
2022 377,692 $2,328,798 0 $0 0 $0
2021 1,165,100 $19,861,600 200,000 $3,753,000 0 $0

Table 2. Monthly summary of insider trading at Erasca, Inc. (ERAS).
Trading Period Insider Buying Insider Sales Option Exercises
year-month Shares Value Shares Value Shares Value
2024-05 80,000 $181,920 0 $0 0 $0
2023-12 1,040,000 $1,764,458 0 $0 0 $0
2023-10 1,000,000 $2,025,999 0 $0 0 $0
2023-06 100,000 $275,000 0 $0 0 $0
2023-04 20,000 $55,240 0 $0 0 $0
2023-03 100,000 $284,000 0 $0 0 $0
2022-12 377,692 $2,328,798 0 $0 0 $0
2021-08 200,000 $4,420,000 0 $0 0 $0
2021-07 965,100 $15,441,600 200,000 $3,753,000 0 $0

Table 3. Detailed insider trading at Erasca, Inc. (ERAS)
  Trade Date   Insider Name Trade Type     Shares       Price ($)   Value ($)
2024-05-21 Casdin Alexander W. (Director) Buy 80,000 2.27 181,920
2023-12-06 Start Valerie Denise Harding (Director) Buy 10,000 1.85 18,480
2023-12-06 Lim Jonathan E (Chairman & CEO) Buy 278,150 1.72 478,418
2023-12-05 Lim Jonathan E (Chairman & CEO) Buy 721,850 1.69 1,217,760
2023-12-04 Casdin Alexander W. (Director) Buy 30,000 1.66 49,800
2023-10-05 Lim Jonathan E (Chairman & CEO) Buy 1,000,000 2.03 2,025,999
2023-06-08 Lim Jonathan E (Chairman & CEO) Buy 100,000 2.75 275,000
2023-04-10 Casdin Alexander W. (Director) Buy 20,000 2.76 55,240
2023-03-28 Lim Jonathan E (Chairman & CEO) Buy 100,000 2.84 284,000
2022-12-21 Bristol James Arthur (Director) Buy 20,000 4.14 82,800
2022-12-21 Start Valerie Denise Harding (Director) Buy 10,000 4.64 46,400
2022-12-14 Lim Jonathan E (Chairman & CEO) Buy 40,000 4.99 199,600
2022-12-13 Cormorant Private Healthcare Fund Ii, Lp Buy 307,692 6.50 1,999,998
2021-08-10 Chen Bihua Buy 200,000 22.10 4,420,000
2021-07-26 Chen Bihua Sale 200,000 18.77 3,753,000
2021-07-20 Cormorant Private Healthcare Fund Ii, Lp Buy 950,000 16.00 15,200,000
2021-07-20 Start Valerie Denise Harding (Director) Buy 2,000 16.00 32,000
2021-07-20 Multani Pratik S (Director) Buy 6,200 16.00 99,200
2021-07-20 Hambleton Julie (Director) Buy 6,000 16.00 96,000
2021-07-20 Garner Ebun (General Counsel) Buy 900 16.00 14,400

Insider trading activities including stock purchases, stock sales, and option exercises of ERAS listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Erasca, Inc. (symbol ERAS, CIK number 1761918) see the Securities and Exchange Commission (SEC) website.



©2023, insider-monitor.com. All rights reserved.